DORRIDGE SURGERY — All Prescriptions & Medications — Page 3
Practice Code: M89010 | SOLIHULL, B93 8LH
Showing results 101-150 of 604
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Combined ethinylestradiol 30mcg | 332 | 32.7K | £2.5K | +19.5% ▲ |
| Insulin aspart | 330 | 2,134 | £16.3K | -13.3% ▼ |
| Lactulose | 329 | 163.2K | £1.5K | -0.1% vs avg |
| Methylphenidate hydrochloride | 325 | 12.8K | £14.5K | +25.8% ▲ |
| Sacubitril/valsartan | 319 | 23.6K | £38.6K | +33.2% ▲ |
| Lamotrigine | 317 | 32.8K | £6.5K | -46.3% ▼ |
| Pravastatin sodium | 316 | 17.3K | £774 | -2.7% ▼ |
| Ready to serve 2.4 kcal/ml milkshake lower volume (0913011) | 315 | 1.5M | £18.2K | +154.2% ▲ |
| Atenolol | 313 | 16.4K | £351 | -48.1% ▼ |
| Loperamide hydrochloride | 311 | 28.5K | £2.1K | +33.5% ▲ |
| Levetiracetam | 304 | 46.4K | £9.7K | -33.6% ▼ |
| 295 | 3,965 | £1.2K | +41.1% ▲ | |
| Rivaroxaban | 294 | 16.2K | £11.2K | -51.9% ▼ |
| Trimethoprim | 291 | 11.2K | £732 | +42.4% ▲ |
| 283 | 34.3K | £1.3K | -40.4% ▼ | |
| Famotidine | 281 | 13.8K | £7.8K | -42.4% ▼ |
| Dexamethasone | 279 | 1,470 | £917 | +62.3% ▲ |
| Quinine sulfate | 271 | 12.6K | £2.0K | -6.4% ▼ |
| Loratadine | 264 | 17.3K | £416 | +26.3% ▲ |
| Buprenorphine | 253 | 1,120 | £5.1K | -30.9% ▼ |
| Methotrexate | 253 | 7,211 | £3.3K | -22.3% ▼ |
| 249 | 3,235 | £2.0K | -0.2% vs avg | |
| Insulin glargine | 245 | 1,473 | £10.2K | -13.7% ▼ |
| Emollient bath and shower preparations | 243 | 150.7K | £2.2K | +286.9% ▲ |
| Esomeprazole | 240 | 16.2K | £1.5K | -40.7% ▼ |
| 238 | 25.2K | £2.0K | +195.8% ▲ | |
| Glyceryl trinitrate | 232 | 1,533 | £685 | -1.9% vs avg |
| Ispaghula husk | 231 | 12.5K | £2.3K | +75.4% ▲ |
| Betahistine hydrochloride | 225 | 26.8K | £1.1K | -5.8% ▼ |
| 219 | 25.5K | £1.1K | -20.8% ▼ | |
| Brinzolamide | 217 | 1,860 | £1.5K | +67.0% ▲ |
| Typhoid | 213 | 213 | £2.2K | +136.5% ▲ |
| 212 | 227 | £1.3K | -10.3% ▼ | |
| Cefalexin | 211 | 6,810 | £560 | +81.4% ▲ |
| Temazepam | 209 | 6,797 | £6.0K | +265.4% ▲ |
| Lymecycline | 209 | 11.9K | £1.4K | +73.8% ▲ |
| Hydrocortisone | 208 | 5,565 | £1.5K | +173.9% ▲ |
| Prochlorperazine maleate | 204 | 6,795 | £491 | +0.9% vs avg |
| 204 | 5,683 | £2.1K | +163.8% ▲ | |
| Nystatin | 203 | 6,330 | £363 | +101.4% ▲ |
| Bumetanide | 199 | 11.6K | £1.1K | -27.0% ▼ |
| Diltiazem hydrochloride | 199 | 16.2K | £2.3K | -35.2% ▼ |
| Empagliflozin | 199 | 9,604 | £11.9K | -68.2% ▼ |
| Quetiapine | 196 | 14.1K | £3.5K | -68.5% ▼ |
| Bimatoprost | 196 | 2,700 | £1.7K | +31.9% ▲ |
| Co-amoxiclav (Amoxicillin/clavulanic acid) | 195 | 6,366 | £608 | +27.7% ▲ |
| Estriol | 191 | 2,704 | £3.7K | -10.2% ▼ |
| Tadalafil | 185 | 5,060 | £1.6K | +8.8% ▲ |
| Fluticasone propionate (Nasal) | 184 | 1,438 | £2.8K | +26.4% ▲ |
| Hepatitis A | 183 | 183 | £3.5K | +141.0% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.